Effectiveness and safety of rivaroxaban therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry

Thrombosis and Haemostasis
Judith HeckerJan Beyer-Westendorf

Abstract

The effectiveness and safety of rivaroxaban for stroke prevention in atrial fibrillation (SPAF) demonstrated in ROCKET AF needs to be confirmed in daily care. To evaluate effectiveness and safety of rivaroxaban therapy in SPAF patients in daily care, we used data from an ongoing, prospective, non-interventional registry of more than 2700 patients on novel oral anticoagulants in daily care. Between October 1, 2011 and February 28, 2013, a total of 1204 SPAF patients receiving rivaroxaban were enrolled. During a mean follow-up of 796.2 ± 207.3 days, the combined endpoint of stroke/transient ischaemic attack/systemic embolism occurred at a rate of 2.03/100 patient-years in the intention-to-treat analysis (95 % confidence interval [CI] 1.5-2.7) and at 1.7/100 patient-years in the on-treatment analysis (events within 3 days after last intake). On-treatment rates were higher in patients selected for 15 mg rivaroxaban (n=384) once daily [OD] compared with the 820 patients selected for 20 mg OD (2.7 [95 % CI 1.6-4.2] vs 1.25/100 patient-years [95 % CI 0.8-1.9]). On treatment, major bleeding occurred at a rate of 3.0/100 patient-years and significantly more often in patients receiving the 15 mg OD dose compared with the 20 mg OD dose (4...Continue Reading

Associated Clinical Trials

References

Jan 23, 1998·Journal of Internal Medicine·F H SteffensenH T Sørensen
Apr 22, 2005·Journal of Thrombosis and Haemostasis : JTH·S SchulmanUNKNOWN Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on T
Oct 21, 2010·Circulation. Cardiovascular Quality and Outcomes·Margaret C FangDaniel E Singer
Aug 13, 2011·The New England Journal of Medicine·Manesh R PatelUNKNOWN ROCKET AF Investigators
Nov 28, 2012·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Tara GomesDavid N Juurlink
Apr 30, 2013·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Hein HeidbuchelUNKNOWN European Heart Rhythm Association
May 7, 2013·BMJ Open·Rikke SørensenMorten Lock Hansen
Sep 11, 2013·Journal of Blood Medicine·David Snipelisky, Fred Kusumoto
Mar 22, 2014·Current Medical Research and Opinion·François LalibertéPatrick Lefebvre
Mar 25, 2014·European Heart Journal·Jonathan P PicciniUNKNOWN ROCKET AF Investigators
Apr 5, 2014·British Journal of Clinical Pharmacology·Jan Beyer-WestendorfNorbert Weiss
Sep 7, 2014·The American Journal of Medicine·Torben Bjerregaard LarsenGregory Y H Lip
Feb 20, 2015·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Jan Beyer-WestendorfNorbert Weiss
Sep 12, 2015·Thrombosis and Haemostasis·Meytal Avgil-TsadokL Pilote

❮ Previous
Next ❯

Citations

Sep 15, 2016·Thrombosis and Haemostasis·Jan Beyer-WestendorfSally Tamayo
Mar 21, 2017·Expert Review of Cardiovascular Therapy·Gonzalo Barón-EsquiviasMarcelo Sanmartín Fernandez
Feb 18, 2017·Journal of Gastroenterology·Sven PannachJan Beyer-Westendorf
Nov 26, 2016·Interventional Cardiology Clinics·Mikhail S DzeshkaGregory Y H Lip
Jul 6, 2017·Expert Opinion on Drug Safety·José Miguel Rivera-CaravacaGregory Y H Lip
Jun 1, 2018·Future Cardiology·Yesenia Pimentel QuezadaÁngel Gallego de la Sacristana López-Serrano
May 24, 2018·Diabetic Medicine : a Journal of the British Diabetic Association·Y-G LiG Y H Lip
Jul 10, 2018·Journal of Cardiovascular Pharmacology·Agnieszka Janion-SadowskaAnetta Undas
Oct 3, 2018·Expert Opinion on Drug Metabolism & Toxicology·Ylenia IngrasciottaGianluca Trifirò
Mar 27, 2019·Current Medical Research and Opinion·Cesar Caro MartinezSergio Manzano Fernández
Dec 29, 2018·The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology·Carlos Arturo Areán MartínezUNKNOWN XANTUS Investigators
Jul 25, 2019·Current Medical Research and Opinion·Begoña Navarro-AlmenzarSergio Manzano-Fernández
Nov 28, 2019·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·A J W M de VeerJ M Ten Berg
Oct 22, 2016·Thrombosis Journal·Lai Heng Lee
Sep 14, 2017·Expert Review of Hematology·Mikhail S DzeshkaGregory Y H Lip
May 2, 2018·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Géric MauraAntoine Pariente
Jul 1, 2017·Thrombosis and Haemostasis·Gregory Y H LipTatjana S Potpara
Jan 10, 2017·Thrombosis and Haemostasis·Christian Weber, Gregory Y H Lip
Dec 4, 2019·Thrombosis Research·Walter BialkowskiUNKNOWN NHLBI Recipient Epidemiology and Donor Evaluation (REDS)-III Study
Aug 27, 2021·TH Open : Companion Journal to Thrombosis and Haemostasis·Jan Beyer-WestendorfWalid Amara

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.